Monthly archive | PharmaTutor

24 October 2025

Pharma Research position at Birla Institute of Technology, Mesra | M.Pharm, M.Sc Biotech /Life Sciences

M.Pharm , M.Sc (Biotech) /Life Sciences with GPAT , UGC- NET, CSIR-NET qualified at Birla Institute of Technology, Mesra

24 October 2025

Apply online for MPharm / MSc at CDRI - 2 posts

M.Sc. in Chemistry or M.Pharma in Medicinal Chemistry with CSIR-UGC/ICMR/ICAR, NET incl. lectureship/assistant professorship or GATE. Central Drug Research Institute

24 October 2025

Apply for position of Project Intern in a ANRF funded research at Birla Institute of Technology, Mesra

Students in undergraduate engineering B.Pharm or postgraduate science, M.Pharm. Birla Institute of Technology, Mesra

24 October 2025

Career for Project Scientist at Institute for Stem Cell Science & Regenerative Medicine

Postgraduate degree in Biotechnology/Microbiology / Medical Microbiology / Molecular Biology / Virology at Institute for Stem Cell Science and Regenerative Medicine

24 October 2025

Career opportunity at Sun Pharma as Officer / Sr. Officer - QC, QA, Microbiology

Sun pharma openings for B.Pharm, M.Pharm, M.Sc as Officer / Sr. Officer in QC, QA, Microbiology departments

24 October 2025

Walk-in-interview for Analytical R&D-API at Sai Life Sciences

Walk-in-interview for Analytical R&D-API CDMO, for R&D Campus, Shameerpet of Sai Life Sciences. M.Sc./ M.Pharm

24 October 2025

Walk in for M.Pharmacy / B.Pharmacy / MSc at Biological E. Limited

Walk in for M.Pharmacy / B.Pharmacy / MSc at Biological E. Limited Speciality Injectables Business located in Shamirpet, Hyderabad. PRODUCTION PHARMA, QUALITY CONTROL, MICROBIOLOGY

24 October 2025

Walk in drive at Bangalore - Dr. Reddy's Lab for Production/Manufacturing, Engineering, IPQA, Bioassay

Dr. Reddys Laboratories opening in Production/Manufacturing, Engineering, IPQA, Bioassay for B.Pharm / M.Pharm / M.Sc, M-Tech Biotech / B-Tech Biotech

23 October 2025

Biocon Biologics receives approval of Psoriasis biosmilar in Canada

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that Health Canada has granted a Notice of Compliance (NOC) for Yesintek™ (ustekinumab injection) and Yesintek™ I.V., a biosimilar to Stelara® (ustekinumab injection) and Stelara® I.V. (ustekinumab for injection, solution for intravenous infusion). The approval was granted on October 17, paving the way for Canadian commercial availability in mid-October.